# Plasma Biomarker in Amblyopia Patients

> **NCT05705778** · — · RECRUITING · sponsor: **Zhongshan Ophthalmic Center, Sun Yat-sen University** · enrollment: 600 (estimated)

## Conditions studied

- Amblyopia

## Interventions

- **PROCEDURE:** standard amblyopia treatment

## Key facts

- **NCT ID:** NCT05705778
- **Lead sponsor:** Zhongshan Ophthalmic Center, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05705778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05705778, "Plasma Biomarker in Amblyopia Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05705778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*